Literature DB >> 2781241

Evidence of the intact hepatocyte theory in alcoholic cirrhosis.

M Vaubourdolle1, V Gufflet, J Guechot, F Ballet, P Jaillon, J Giboudeau, R Poupon.   

Abstract

To improve our understanding of the predominant operational model involved in the decreased clearance in cirrhosis, hepatic clearance, the extraction ratio of indocyanine green, and liver plasma flow were estimated in cirrhosis, either with a method based on the Fick principle or with a pharmacokinetic method assuming a bicompartmental plasma elimination of the dye. The two methods gave similar values for clearance. In contrast, the pharmacokinetic analysis gave significantly (p less than 0.01) lower hepatic plasma flow values and significantly (p less than 0.01) higher extraction values than those obtained with the reference (Fick principle) method. The main finding of this work is that in these cirrhotic patients, as in normal subjects, 'cellular' extraction estimated by the pharmacokinetic method is in the range of 0.60-0.80, whereas the extraction by the entire liver, assessed by the reference method, is low. In chronic liver diseases such as cirrhosis these data support the predominance of the intact hepatocyte theory, which assumes the existence of intrahepatic shunts associated with normally perfused and normally extracting hepatocytes. In acute liver disease, a cellular damage could be superadded.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781241     DOI: 10.3109/00365528909093076

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Liver metabolic zonation and hepatic microcirculation in carbon tetrachloride-induced experimental cirrhosis.

Authors:  E Gaudio; P Onori; A Franchitto; R Sferra; O Riggio
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

2.  The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis.

Authors:  Liping Liu; Govardhana Rao Yannam; Taichiro Nishikawa; Toshiyuki Yamamoto; Hesham Basma; Ryotaro Ito; Masaki Nagaya; Joyeeta Dutta-Moscato; Donna B Stolz; Fenghai Duan; Klaus H Kaestner; Yoram Vodovotz; Alejandro Soto-Gutierrez; Ira J Fox
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

3.  Resetting the transcription factor network reverses terminal chronic hepatic failure.

Authors:  Taichiro Nishikawa; Aaron Bell; Jenna M Brooks; Kentaro Setoyama; Marta Melis; Bing Han; Ken Fukumitsu; Kan Handa; Jianmin Tian; Klaus H Kaestner; Yoram Vodovotz; Joseph Locker; Alejandro Soto-Gutierrez; Ira J Fox
Journal:  J Clin Invest       Date:  2015-03-16       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.